Picture EBD Group Digital Medicine & Medtech Showcase 2021 at BTS2021 651x81
Document › Details

Therametrics Holding AG. (9/3/13). "Press Release: Therametrics Holding AG (SIX: TMX) Today Announces the Resignation of Mr. Ruggero Gramatica as CEO and Director as of the End of September 2013 and the Appointment of Mr. Raffaele Petrone as New CEO with

Organisations Organisation Therametrics Holding AG
  Today Relief Therapeutics Holding AG (SIX: RLF, OTCQB: RLFTF)
  Group Relief Therapeutics (Group)
  Organisation 2 Pierrel Research International AG
Products Product drug discovery services
  Product 2 contract research (drugs)
Persons Person Petrone, Raffaele (Therametrics 201310– CEO)
  Person 2 Gramatica, Ruggero (Therametrics –201309 CEO RESIGNED 9/13)

THERAMetrics holding AG today announces that,after having successfully accomplished the restructuring and turn­around of the company, Mr. Ruggero Gramatica has resigned from the position of  CEO and board member with effect as of the end of September 2013. The board of directors has appointed the Chairman of the company, Mr. Raffaele Petrone, as new CEO as from 1October 2013.

Mr. Gramatica will be completing the business combination of THERAMetrics group with Pierrel Research International AG, which had been announced on 24 January 2013 and approved by the shareholders of THERAMetrics holding AG at the ordinary shareholders meeting of 20 June 2013. In parallel, he will gradually be handing over to Mr. Petrone who will, as new CEO of THERAMetrics holding AG, be in charge with the integration of Pierrel Research International AG into THERAMetrics group.

Mr. Raffaele Petrone,of THERAMetrics holding AG, commented: "We thank Mr. Gramatica for having successfully conducted the company through a very difficult turn­around, having created new value and paved the way for the set up of an innovative business combination, and also for having prepared in such a thorough way the business combination of THERAMetrics group with Pierrel Research International AG”.

Mr. Ruggero Gramatica added: “It has been a number of very challenging tasks, and I’m happy to be handing over to Mr. Petrone a company that, once the business combination with Pierrel Research International AG has been completed, is set to last as well as to offer new, interesting, and innovative services that will benefit the drug discovery and development companies around the world. Thank to his profound knowledge of Pierrel Research International AG, Mr. Petrone is the right person for the integration of its business into THERAMetrics group.”

About THERAMetrics
Screening potential drugs in virtual biosystems, evaluating therapies in virtual in patients and predicting real­world health outcomes and costs are the main drivers that inspires the Company’s business model. THERAMetrics is a TCRDO (Tech Contract Research & Development Organization) offering full competitive technological solutions through the entire value chain of drug discovery & development and innovative partnerships-alliances business opportunities to Biopharma companies.

For further information pleasecontact
THERAMetrics holding AG
Andreas Hildenbrand,
Lemongrass Communications
Tel.: +41 44 202 5268


This communication expressly or implicitly contains certain forward-looking statements concerning THERAMetrics holding AG and its business. Such statements involve certain known and unknown risks, uncertainties and other factors, which could cause the actual results, financial condition, performance or achievements of THERAMetrics holding AG to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. THERAMetrics holding AG is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise.

Record changed: 2017-04-02


Picture ConsulTech GmbH RnD Credit Germany 650x80px

More documents for Relief Therapeutics (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group Digital Medicine & Medtech Showcase 2021 at BTS2021 651x81

» top